UK digital pathology market is expected to grow at a CAGR of approximately 14.2% during the forecast period. Increasing UK government focus towards digital pathology is encouraging the demand of digital pathology in the region. For instance, in 2017, Leica Biosystem and UK Office of Life Sciences entered into agreement to support the UK mission to advance AI in pathology. 

The healthcare providers, including NHS trust polymouth hospitals, Derriford hospital are in demand of digital pathology for research and training purpose, which is further encouraging the UK digital pathology market growth. Moreover, CM-Path (National Cancer Research Institute (NCRI)) has taken initiative for reinvigorate academic pathology in the UK. This will provide scope for wider and faster implementation of digital pathology for patient’s benefit. Additionally, there is scope of the current molecular diagnostic and digital pathology attitudes and provisions across the UK. The significant investment by 25 organizations from across the sector and supported by government will ensure the UK is at the forefront of developing new innovative treatments and medical technologies that will improve patient’s life. Various laboratories in the UK have already implemented or are about to implement digital pathology techniques by using whole slide imaging, having evaluated the balance of risks and benefits for the work of their laboratories. This enables to drive the UK digital pathology. 

Visit for Global Digital Pathology Market Report at: https://www.omrglobal.com/industry-reports/digital-pathology-market

Regulations in the UK includes, For WSI devices, the instrument manufacturers are required to obtain regulatory approval before selling a device for diagnostic purpose. It undergoes with quality control of design and manufacturing that ensures the viability of the device. UK government are also taking steps to modernize the industry, expand the small businesses, which is expected to create significant opportunity for the market growth. The government has given the commitment to invest up to $351 million for diagnostics every year by 2020. Additionally, the national health service (NHS) in England announced to invest $17.5 million on the program for faster diagnosis of cancer. This involve funding for productive diagnostic services, trailing new multidisciplinary diagnostic centers and testing of new faster diagnosis standard.  

Research Methodology

The market study of the UK digital pathology market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for digital pathology software, service and devices manufacturers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. UK Digital Pathology Market Research and Analysis by Product and Services

2. UK Digital Pathology Market Research and Analysis by End-user

3. UK Digital Pathology Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the UK Digital Pathology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the UK Digital Pathology market.
• Insights about market determinants which are stimulating the UK Digital Pathology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.